Addition of Loncastuximab Tesirine to Acalbrutinib , Chronic Lymphocytic Leukemia
Clinical trial NCT05971251 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05971251
- Sponsor
- University of Alabama at Birmingham
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-18
- Primary completion
- 2026-12-31
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.